8-Ethoxy-N-((3R,4S)-3-Methyl-1-(Methylsulfonyl)Piperidin-4-Yl)-7-(1H-Pyrazol-4-Yl)-[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine

2 trials 1 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

8 Countries

Phase III

Phase II

Phase III: 1 Phase II: 1

Indications tested

Ovarian cancer 2

Sponsors using this IMP

All trials

2 total

Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending

2025-522748-42-00 Phase III 8 countries Incyte Corp.
Phase 2 Study of INCB123667 in Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Recruiting

2025-521513-14-00 Phase II 2 countries Incyte Corp.

Showing 1–2 of 2 trials

← All drugs A–Z